See All Slides - tctmd.com

Slides

Presentation THT 2024

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Presenter: Maria Rosa Costanzo

March 06, 2024

Presentation THT 2024

Bringing the Perfect Heart to the OR

Presenter: Christopher Salerno

March 06, 2024

Presentation THT 2024

One Ring to Rule Them All: The Promise of Sotatercept in PH (PAH and Left Heart Disease)

Presenter: Ioana Preston

March 06, 2024

Presentation THT 2024

Counter Pulsation of the PA: Aria CV

Presenter: Jane A. Leopold

March 06, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

PADN for PH in Left Heart Disease

Presenter: Greg Lewis

March 06, 2024

Presentation THT 2024

Emerging Therapies for Residual Pulmonary Hypertension After Pulmonary Endarterectomy

Presenter: Paul Forfia

March 06, 2024

Presentation THT 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presenter: Thomas Hanff

March 06, 2024

Presentation THT 2024

Pulmonary Artery Denervation

Presenter: Alex M. K. Rothman

March 06, 2024

Presentation THT 2024

DPP3-Based Biotherapy in Cardiogenic Shock

Presenter: Mahir Karakas

March 06, 2024

Advertisement

Slides

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Bringing the Perfect Heart to the OR

One Ring to Rule Them All: The Promise of Sotatercept in PH (PAH and Left Heart Disease)

Counter Pulsation of the PA: Aria CV

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

PADN for PH in Left Heart Disease

Emerging Therapies for Residual Pulmonary Hypertension After Pulmonary Endarterectomy

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Pulmonary Artery Denervation

DPP3-Based Biotherapy in Cardiogenic Shock

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content